ADAGIO THERAPEUTICS INC (ADGI) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ADGI • US00534A1025

4.64 USD
+0.04 (+0.87%)
At close: Sep 12, 2022
4.52 USD
-0.12 (-2.59%)
After Hours: 9/12/2022, 8:13:11 PM
Fundamental Rating

2

Overall ADGI gets a fundamental rating of 2 out of 10. We evaluated ADGI against 524 industry peers in the Biotechnology industry. While ADGI seems to be doing ok healthwise, there are quite some concerns on its profitability. ADGI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ADGI had negative earnings in the past year.
ADGI Yearly Net Income VS EBIT VS OCF VS FCFADGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 -50M -100M -150M -200M

1.2 Ratios

Industry RankSector Rank
ROA -60.89%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADGI Yearly ROA, ROE, ROICADGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 -20 -40 -60

1.3 Margins

  • ADGI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADGI Yearly Profit, Operating, Gross MarginsADGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

6

2. Health

2.1 Basic Checks

  • The number of shares outstanding for ADGI has been increased compared to 1 year ago.
  • ADGI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ADGI Yearly Shares OutstandingADGI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 20M 40M 60M 80M 100M
ADGI Yearly Total Debt VS Total AssetsADGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 200M 400M 600M

2.2 Solvency

  • ADGI has an Altman-Z score of 2.06. This is not the best score and indicates that ADGI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • There is no outstanding debt for ADGI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.06
ROIC/WACCN/A
WACCN/A
ADGI Yearly LT Debt VS Equity VS FCFADGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 200M 400M

2.3 Liquidity

  • ADGI has a Current Ratio of 7.09. This indicates that ADGI is financially healthy and has no problem in meeting its short term obligations.
  • ADGI has a Quick Ratio of 7.09. This indicates that ADGI is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 7.09
Quick Ratio 7.09
ADGI Yearly Current Assets VS Current LiabilitesADGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 200M 400M 600M

More info and screens

0

3. Growth

3.1 Past

  • ADGI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -74.66%.
EPS 1Y (TTM)-74.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-161.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 2.19% on average over the next years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2.35%
EPS Next 2Y7.44%
EPS Next 3Y12.17%
EPS Next 5Y2.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ADGI Yearly Revenue VS EstimatesADGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 200M 400M 600M 800M
ADGI Yearly EPS VS EstimatesADGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ADGI. In the last year negative earnings were reported.
  • Also next year ADGI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADGI Price Earnings VS Forward Price EarningsADGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADGI Per share dataADGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

  • ADGI's earnings are expected to grow with 12.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.44%
EPS Next 3Y12.17%

More info and screens

0

5. Dividend

5.1 Amount

  • ADGI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ADAGIO THERAPEUTICS INC / ADGI FAQ

Can you provide the ChartMill fundamental rating for ADAGIO THERAPEUTICS INC?

ChartMill assigns a fundamental rating of 2 / 10 to ADGI.


What is the valuation status for ADGI stock?

ChartMill assigns a valuation rating of 1 / 10 to ADAGIO THERAPEUTICS INC (ADGI). This can be considered as Overvalued.


Can you provide the profitability details for ADAGIO THERAPEUTICS INC?

ADAGIO THERAPEUTICS INC (ADGI) has a profitability rating of 1 / 10.


What is the financial health of ADAGIO THERAPEUTICS INC (ADGI) stock?

The financial health rating of ADAGIO THERAPEUTICS INC (ADGI) is 5 / 10.